Pathstone Holdings’s DarioHealth DRIO Stock Holding History

Pathstone Holdings’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-769	Closed	-$12.1K	–	2294
2024 Q4	$12.1K	Buy	+769	New	+$13.3K	﹤0.01%	2295

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return

Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DIM

DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return

Pathstone Holdings's DRIO Position: Q1 2025 in Review

Pathstone Holdings sold out of DarioHealth (DRIO) in Q1 2025, closing a stake of 769 shares — an estimated $12.1K sold.

Pathstone Holdings first reported a position in DRIO in Q4 2024 and held it in 1 quarter. The position peaked at $12.1K in Q4 2024. 42 funds tracked by Wall St. Rank hold DRIO as of Q1 2025.

Pathstone Holdings reported no remaining DarioHealth position as of Q1 2025 after selling out during the quarter.
Pathstone Holdings sold 769 DarioHealth shares in Q1 2025, an estimated $12.1K.
Pathstone Holdings first reported a position in DarioHealth in Q4 2024 and held it in 1 quarter.
Pathstone Holdings's DarioHealth position peaked at $12.1K in Q4 2024.
42 funds tracked by Wall St. Rank held DarioHealth as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.